You are here

Home

Treatments

U.S. FDA vaccine advisers reported upset that early data about new Moderna Covid-19 booster shot wasn’t presented for review last year

Wed, 2023-01-11 15:06 — mike kraft
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN Some vaccine advisers to the federal government say they're "disappointed" and "angry" that government scientists and the pharmaceutical company Moderna didn't present a set of infection data on the company's new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public. Elizabeth Cohen,Naomi Thomas CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Merck's COVID treatment expected to launch in China on Friday

Wed, 2023-01-11 14:50 — mike kraft
Merck's COVID treatment expected to launch in China on Friday Merck & Co's COVID-19 antiviral treatment molnupiravir is expected to be launched in the Chinese market on Friday, Sinopharm's president Liu Yong was quoted as saying by state-backed media outlet Kankan News on Wednesday. Reuters Reuters

 

Country / Region Tags: 
China
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Mutations
Pandemics
Public Health
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Global COVID vaccine acceptance rose 5% from 2021 to 2022 --survey

Wed, 2023-01-11 00:08 — mike kraft
Global COVID vaccine acceptance rose 5% from 2021 to 2022 CIDRAP

COVID-19 vaccine acceptance climbed from 75% in 2021 to 79% in 2022 in 23 countries representing nearly 60% of the global population, finds a survey published yesterday in Nature Medicine.

...

In eight countries, however, vaccine hesitancy increased (range, 1.0% in the United Kingdom to 21.1% in South Africa). And nearly 1 in 8 of all respondents (12.1%), particularly those aged 18 to 29 years, said they were hesitant to receive a booster dose (range, 1.1% in China to 28.9% in Russia).

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Attitudes
Public Health
Research
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Moderna reported to charge $130 for Covid vaccine dose, Senator Sanders calls the charges outrageous

Tue, 2023-01-10 23:30 — mike kraft
Sanders tells Moderna planned COVID vaccine price hike is ‘unacceptable corporate greed’ Sen. Bernie Sanders (I-Vt.) is calling on Moderna not to quadruple the price of its COVID-19 vaccine, saying Tuesday that the plan amounts to “unacceptable corporate greed.” In a Tuesda… nweixel The Hill

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

Omicron COVID booster cuts hospitalization in over 65s -- Israeli study

Mon, 2023-01-09 15:42 — mike kraft
Omicron COVID booster cuts hospitalization in over 65s, Israeli study finds The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab's real-world effectiveness. Reuters Reuters
Country / Region Tags: 
Global
Israel
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

New studies outline Omicron immune protection after infection, vaccination

Mon, 2023-01-09 15:37 — mike kraft
Studies detail Omicron immune protection after infection, vaccination One study looked at BA.5 infection after vaccination, while another examined vaccine effectiveness in children and adolescents. CIDRAP

A pair of new studies describe infection- and vaccine-conferred immunity against the SARS-CoV-2 Omicron variant, with one showing that vaccinated people have good protection against BA.5 subvariant reinfection for at least 8 months after infection, and the other finding that the vaccine is 46% and 70% effective against infection and hospitalization, respectively, in children.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Data
Demographics
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

China’s Covid wave threatens delays in U.S. and other medical supply chains

Mon, 2023-01-09 15:11 — mike kraft
China’s Covid wave threatens another snarl of U.S. medical supply chain U.S. efforts to lessen the health care system's reliance on China will be tested in the coming weeks and months as the coronavirus rolls through China. NBC News
Country / Region Tags: 
China
Global
United States
General Topic Tags: 
Capacity
COVID-19
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Scarcity
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

People who haven't had COVID will likely catch the new XBB.1.5 variant, experts say

Fri, 2023-01-06 22:44 — mike kraft
People who haven't had COVID will likely catch XBB.1.5 – and many will get reinfected, experts say New COVID variant XBB.1.5 is very contagious, meaning everyone is at risk for infection even if you've already had COVID. Here's what that means. YahooNews
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Contagion
Data
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

CureVac says COVID vaccine produced immune response in early-stage trial

Fri, 2023-01-06 14:19 — mike kraft
CureVac says COVID vaccine produced immune response in early-stage trial Germany's CureVac AG said on Friday its second-generation COVID-19 vaccine produced virus-neutralizing antibodies against the BA.1 subvariant of Omicron, based on preliminary data from an early-stage trial. Reuters Reuters

...

Country / Region Tags: 
Germany
Global
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Florida surgeon general used ‘flawed’ science to discourage vaccinations -- university faculty peers

Thu, 2023-01-05 15:56 — mike kraft
Fla. surgeon general used ‘flawed’ vaccine science, faculty peers say Joseph A. Ladapo may have violated University of Florida research integrity rules, a faculty task force said.
Country / Region Tags: 
United States
US - South
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Policy
Politics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.661 seconds.